...
首页> 外文期刊>Neuropsychopharmacology >Effects of Acute Oral Naltrexone on the Subjective and Physiological Effects of Oral D-Amphetamine and Smoked Cocaine in Cocaine Abusers
【24h】

Effects of Acute Oral Naltrexone on the Subjective and Physiological Effects of Oral D-Amphetamine and Smoked Cocaine in Cocaine Abusers

机译:急性口服纳曲酮对可卡因滥用者口服D-苯丙胺和烟熏可卡因的主观和生理影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Despite the prevalent worldwide abuse of stimulants, such as amphetamines and cocaine, no medications are currently approved for treating this serious public health problem. Both preclinical and clinical studies suggest that the opioid antagonist naltrexone (NTX) is effective in reducing the abuse liability of amphetamine, raising the question of whether similar positive findings would be obtained for cocaine. The purpose of this study was to evaluate the ability of oral NTX to alter the cardiovascular and subjective effects of D-amphetamine (D-AMPH) and cocaine (COC). Non-treatment-seeking COC users (N=12) completed this 3-week inpatient, randomized, crossover study. Participants received 0, 12.5, or 50?mg oral NTX 60?min before active or placebo stimulant administration during 10 separate laboratory sessions. Oral AMPH (0, 10, and 20?mg; or all placebo) was administered in ascending order within a laboratory session using a 60-min interdose interval. Smoked COC (0, 12.5, 25, and 50?mg; or all placebo) was administered in ascending order within a laboratory session using a 14-min interdose interval. Active COC and AMPH produced dose-related increases in cardiovascular function that were of comparable magnitude. In contrast, COC, but not AMPH, produced dose-related increases in several subjective measures of positive drug effect (eg, high, liking, and willingness to pay for the drug). NTX did not alter the cardiovascular effects of AMPH or COC. NTX also did not alter positive subjective ratings after COC administration, but it did significantly reduce ratings of craving for COC and tobacco during COC sessions. These results show that (1) oral AMPH produces minimal abuse-related subjective responses in COC smokers, and (2) NTX reduces craving for COC and tobacco during COC sessions. Future studies should continue to evaluate NTX as a potential anti-craving medication for COC dependence.
机译:尽管全世界普遍滥用苯丙胺和可卡因等兴奋剂,但目前尚无任何药物可用于治疗这一严重的公共卫生问题。临床前和临床研究均表明,阿片样物质拮抗剂纳曲酮(NTX)可有效降低苯丙胺的滥用风险,这引发了关于可卡因能否获得类似阳性结果的问题。这项研究的目的是评估口服NTX改变D-苯丙胺(D-AMPH)和可卡因(COC)的心血管和主观作用的能力。非寻求治疗的COC使用者(N = 12)完成了为期3周的住院,随机,交叉研究。在10个单独的实验室会议中,在积极或安慰剂刺激前60分钟,参与者接受0、12.5或50?mg口服NTX。口服AMPH(0、10和20?mg;或所有安慰剂)在实验室疗程中以60分钟的剂量间隔以升序给药。抽烟的COC(0、12.5、25和50?mg;或所有安慰剂)在实验室会议期间以14分钟的剂量间隔以升序给药。活跃的COC和AMPH可导致剂量相关的心血管功能增加,其幅度相当。相比之下,COC而非AMPH会在几种积极的药物作用主观指标(例如,高,喜好和愿意付款)上产生剂量相关的增加。 NTX不会改变AMPH或COC的心血管作用。 NTC服用COC后也没有改变阳性主观评分,但确实降低了COC期间对COC和烟草的渴望评分。这些结果表明,(1)口服AMPH在COC吸烟者中产生的滥用相关主观反应最少,(2)NTX减少了COC期间对COC和烟草的渴望。未来的研究应继续评估NTX作为COC依赖的潜在抗渴药。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号